Healthcare utilisation in patients with long-term conditions during the COVID-19 pandemic: a population-based observational study of all patients across Greater Manchester, UK.
COVID-19
Epidemiology
Public health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
07 07 2023
07 07 2023
Historique:
medline:
10
7
2023
pubmed:
8
7
2023
entrez:
7
7
2023
Statut:
epublish
Résumé
Data on population healthcare utilisation (HCU) across both primary and secondary care during the COVID-19 pandemic are lacking. We describe primary and secondary HCU stratified by long-term conditions (LTCs) and deprivation, during the first 19 months of COVID-19 pandemic across a large urban area in the UK. A retrospective, observational study. All primary and secondary care organisations that contributed to the Greater Manchester Care Record throughout 30 December 2019 to 1 August 2021. 3 225 169 patients who were registered with or attended a National Health Service primary or secondary care service during the study period. Primary care HCU (incident prescribing and recording of healthcare information) and secondary care HCU (planned and unplanned admissions) were assessed. The first national lockdown was associated with reductions in all primary HCU measures, ranging from 24.7% (24.0% to 25.5%) for incident prescribing to 84.9% (84.2% to 85.5%) for cholesterol monitoring. Secondary HCU also dropped significantly for planned (47.4% (42.9% to 51.5%)) and unplanned admissions (35.3% (28.3% to 41.6%)). Only secondary care had significant reductions in HCU during the second national lockdown. Primary HCU measures had not recovered to prepandemic levels by the end of the study. The secondary admission rate ratio between multi-morbid patients and those without LTCs increased during the first lockdown by a factor of 2.40 (2.05 to 2.82; p<0.001) for planned admissions and 1.25 (1.07 to 1.47; p=0.006) for unplanned admissions. No significant changes in this ratio were observed in primary HCU. Major changes in primary and secondary HCU were observed during the COVID-19 pandemic. Secondary HCU reduced more in those without LTCs and the ratio of utilisation between patients from the most and least deprived areas increased for the majority of HCU measures. Overall primary and secondary care HCU for some LTC groups had not returned to prepandemic levels by the end of the study.
Identifiants
pubmed: 37419643
pii: bmjopen-2022-066873
doi: 10.1136/bmjopen-2022-066873
pmc: PMC10335594
doi:
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e066873Subventions
Organisme : Department of Health
ID : NIHR200174
Pays : United Kingdom
Organisme : Department of Health
ID : IS-BRC-1215-20007
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR200174
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Am J Respir Crit Care Med. 2021 Mar 1;203(5):565-574
pubmed: 33306946
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
Injury. 2021 Mar;52(3):395-401
pubmed: 33627252
Heart. 2020 Dec;106(24):1890-1897
pubmed: 33020224
Occup Environ Med. 2020 Dec 9;:
pubmed: 33298533
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33028701
Lancet Public Health. 2020 Oct;5(10):e543-e550
pubmed: 32979305
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
BMJ. 2020 May 15;369:m1932
pubmed: 32414712
J Infect. 2021 Oct;83(4):413-423
pubmed: 34314737
Lancet. 2020 Aug 8;396(10248):381-389
pubmed: 32679111
Antibiotics (Basel). 2021 May 17;10(5):
pubmed: 34067546
BMJ. 2020 Jun 12;369:m2386
pubmed: 32532710
Lancet Reg Health Eur. 2021 Jun 08;7:100144
pubmed: 34557845
BMJ Open. 2021 Mar 16;11(3):e045343
pubmed: 33727273
Ann Oncol. 2020 Aug;31(8):1065-1074
pubmed: 32442581
Eur J Cancer. 2021 Jun;150:190-202
pubmed: 33932726
JAMA. 2020 Sep 22;324(12):1149-1150
pubmed: 32960247
BMJ Open. 2020 Nov 17;10(11):e043828
pubmed: 33203640
Healthc Policy. 2011 May;6(4):e106-17
pubmed: 22548101
Heart. 2020 Dec;106(23):1805-1811
pubmed: 32868280
Int Health. 2021 Sep 3;13(5):399-409
pubmed: 33974687
Prev Med. 2021 Oct;151:106606
pubmed: 34217418
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114